Name | Number of supported studies | Average coverage | |
---|---|---|---|
peripheral blood | 3 studies | 19% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
lung | 100% | 3352.33 | 578 / 578 | 97% | 15.99 | 1122 / 1155 |
skin | 96% | 857.29 | 1745 / 1809 | 100% | 59.55 | 471 / 472 |
kidney | 100% | 1589.92 | 89 / 89 | 94% | 15.71 | 844 / 901 |
esophagus | 100% | 1364.04 | 1442 / 1445 | 93% | 13.66 | 171 / 183 |
uterus | 100% | 1564.09 | 170 / 170 | 93% | 12.02 | 427 / 459 |
ovary | 100% | 1836.97 | 180 / 180 | 92% | 11.23 | 396 / 430 |
breast | 100% | 1178.46 | 457 / 459 | 91% | 10.92 | 1018 / 1118 |
thymus | 100% | 1653.35 | 651 / 653 | 89% | 16.00 | 539 / 605 |
brain | 97% | 1019.32 | 2570 / 2642 | 91% | 8.90 | 640 / 705 |
bladder | 100% | 1477.90 | 21 / 21 | 73% | 8.41 | 369 / 504 |
intestine | 100% | 2104.87 | 962 / 966 | 69% | 6.66 | 364 / 527 |
stomach | 92% | 904.16 | 332 / 359 | 76% | 7.96 | 217 / 286 |
prostate | 99% | 1362.17 | 243 / 245 | 68% | 4.55 | 340 / 502 |
pancreas | 63% | 380.22 | 206 / 328 | 90% | 12.02 | 161 / 178 |
adrenal gland | 93% | 696.37 | 240 / 258 | 38% | 2.08 | 88 / 230 |
liver | 75% | 455.00 | 170 / 226 | 37% | 3.10 | 152 / 406 |
eye | 0% | 0 | 0 / 0 | 100% | 45.30 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 109.07 | 29 / 29 |
peripheral blood | 100% | 19302.68 | 929 / 929 | 0% | 0 | 0 / 0 |
spleen | 100% | 13392.49 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 20.59 | 45 / 45 |
adipose | 100% | 1662.83 | 1200 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 99% | 1354.02 | 1327 / 1335 | 0% | 0 | 0 / 0 |
heart | 81% | 532.08 | 699 / 861 | 0% | 0 | 0 / 0 |
muscle | 12% | 53.08 | 95 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0006954 | Biological process | inflammatory response |
GO_0001779 | Biological process | natural killer cell differentiation |
GO_0045766 | Biological process | positive regulation of angiogenesis |
GO_0045087 | Biological process | innate immune response |
GO_0002679 | Biological process | respiratory burst involved in defense response |
GO_0007165 | Biological process | signal transduction |
GO_0010595 | Biological process | positive regulation of endothelial cell migration |
GO_0010628 | Biological process | positive regulation of gene expression |
GO_0050853 | Biological process | B cell receptor signaling pathway |
GO_0030101 | Biological process | natural killer cell activation |
GO_0030593 | Biological process | neutrophil chemotaxis |
GO_0050852 | Biological process | T cell receptor signaling pathway |
GO_0038084 | Biological process | vascular endothelial growth factor signaling pathway |
GO_0035747 | Biological process | natural killer cell chemotaxis |
GO_0035754 | Biological process | B cell chemotaxis |
GO_0048015 | Biological process | phosphatidylinositol-mediated signaling |
GO_0043303 | Biological process | mast cell degranulation |
GO_0006955 | Biological process | immune response |
GO_0002250 | Biological process | adaptive immune response |
GO_0030217 | Biological process | T cell differentiation |
GO_0036092 | Biological process | phosphatidylinositol-3-phosphate biosynthetic process |
GO_1905278 | Biological process | positive regulation of epithelial tube formation |
GO_0033031 | Biological process | positive regulation of neutrophil apoptotic process |
GO_0001938 | Biological process | positive regulation of endothelial cell proliferation |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0072672 | Biological process | neutrophil extravasation |
GO_0042113 | Biological process | B cell activation |
GO_0043491 | Biological process | phosphatidylinositol 3-kinase/protein kinase B signal transduction |
GO_0016310 | Biological process | phosphorylation |
GO_0001819 | Biological process | positive regulation of cytokine production |
GO_0006468 | Biological process | protein phosphorylation |
GO_0010818 | Biological process | T cell chemotaxis |
GO_0002551 | Biological process | mast cell chemotaxis |
GO_0042110 | Biological process | T cell activation |
GO_0016477 | Biological process | cell migration |
GO_0030183 | Biological process | B cell differentiation |
GO_0060374 | Biological process | mast cell differentiation |
GO_0005886 | Cellular component | plasma membrane |
GO_0005942 | Cellular component | phosphatidylinositol 3-kinase complex |
GO_0005943 | Cellular component | phosphatidylinositol 3-kinase complex, class IA |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005524 | Molecular function | ATP binding |
GO_0016301 | Molecular function | kinase activity |
GO_0016303 | Molecular function | 1-phosphatidylinositol-3-kinase activity |
GO_0035005 | Molecular function | 1-phosphatidylinositol-4-phosphate 3-kinase activity |
GO_0005515 | Molecular function | protein binding |
GO_0046934 | Molecular function | 1-phosphatidylinositol-4,5-bisphosphate 3-kinase activity |
Gene name | PIK3CD |
Protein name | Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta phosphatidylinositol-4,5-bisphosphate 3-kinase (EC 2.7.1.153) Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform (PI3-kinase subunit delta) (PI3K-delta) (PI3Kdelta) (PtdIns-3-kinase subunit delta) (EC 2.7.1.137) (EC 2.7.1.153) (Phosphatidylinositol 4,5-bisphosphate 3-kinase 110 kDa catalytic subunit delta) (PtdIns-3-kinase subunit p110-delta) (p110delta) |
Synonyms | |
Description | FUNCTION: Phosphoinositide-3-kinase (PI3K) phosphorylates phosphatidylinositol (PI) and its phosphorylated derivatives at position 3 of the inositol ring to produce 3-phosphoinositides . Uses ATP and PtdIns(4,5)P2 (phosphatidylinositol 4,5-bisphosphate) to generate phosphatidylinositol 3,4,5-trisphosphate (PIP3) . PIP3 plays a key role by recruiting PH domain-containing proteins to the membrane, including AKT1 and PDPK1, activating signaling cascades involved in cell growth, survival, proliferation, motility and morphology. Mediates immune responses. Plays a role in B-cell development, proliferation, migration, and function. Required for B-cell receptor (BCR) signaling. Mediates B-cell proliferation response to anti-IgM, anti-CD40 and IL4 stimulation. Promotes cytokine production in response to TLR4 and TLR9. Required for antibody class switch mediated by TLR9. Involved in the antigen presentation function of B-cells. Involved in B-cell chemotaxis in response to CXCL13 and sphingosine 1-phosphate (S1P). Required for proliferation, signaling and cytokine production of naive, effector and memory T-cells. Required for T-cell receptor (TCR) signaling. Mediates TCR signaling events at the immune synapse. Activation by TCR leads to antigen-dependent memory T-cell migration and retention to antigenic tissues. Together with PIK3CG participates in T-cell development. Contributes to T-helper cell expansion and differentiation. Required for T-cell migration mediated by homing receptors SELL/CD62L, CCR7 and S1PR1 and antigen dependent recruitment of T-cells. Together with PIK3CG is involved in natural killer (NK) cell development and migration towards the sites of inflammation. Participates in NK cell receptor activation. Plays a role in NK cell maturation and cytokine production. Together with PIK3CG is involved in neutrophil chemotaxis and extravasation. Together with PIK3CG participates in neutrophil respiratory burst. Plays important roles in mast-cell development and mast cell mediated allergic response. Involved in stem cell factor (SCF)-mediated proliferation, adhesion and migration. Required for allergen-IgE-induced degranulation and cytokine release. The lipid kinase activity is required for its biological function. Isoform 2 may be involved in stabilizing total RAS levels, resulting in increased ERK phosphorylation and increased PI3K activity. . |
Accessions | A0A2K8FKV1 A7E2E0 A0A8V8TNW9 ENST00000698715.1 A0A2K8FKT1 O00329 ENST00000698709.1 ENST00000698710.1 ENST00000698789.1 A0A2K8FKQ1 A0A2K8FKR1 ENST00000698712.1 [O00329-1] ENST00000361110.6 B7ZM44 F8W9P4 A0A8V8TML5 ENST00000377346.9 [O00329-1] ENST00000481137.2 [O00329-2] A0A8V8TM62 ENST00000698714.1 ENST00000698713.1 [O00329-1] A0A8V8TMM0 ENST00000698716.1 A0A8V8TNP1 ENST00000698707.1 |